Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Dabigatran [1] Dabigatran[1] Dabigatran 💬 [1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[5] 51, 75, 85, 91, 124 💬
2 Rivaroxaban [1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[6] 46, 49, 56, 91, 210, 271 💬
3 Warfarin [3] Warfarin; Warfarin potassium; Warfarin sodium[3] Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬
[2] NQO1,
VKORC1 💬
[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[12] 6, 8, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬